Estás viendo estas citas basadas en búsquedas anteriores relacionadas con sectores como
Nombre | 7 días netos | Neto 1 mes | Neto 3 mes | Neto 6 mes | Neto 1 año |
---|---|---|---|---|---|
4basebio | n / a | n / a | n / a | n / a | n / a |
Farmacia 4D | n / a | n / a | n / a | n / a | n / a |
Abcam | n / a | n / a | n / a | n / a | n / a |
Abzená | n / a | n / a | n / a | n / a | n / a |
Agronomía limitada | £0 | £0 | £0 | £0 | £45,315 |
Terapias de alergia | £0 | £0 | £0 | £2,481,027 | £2,481,027 |
Alianza Farmacéutica | £0 | £0 | £0 | £0 | £26,063 |
Grupo de cuidado de animales | £0 | £0 | £0 | £0 | £348,787 |
Anpario | £0 | £0 | £24,600 | £24,600 | £24,600 |
Grupo Aptamer | n / a | n / a | n / a | n / a | n / a |
Aqua Bounty Technologies Inc. (Registro S) | n / a | n / a | n / a | n / a | n / a |
Terapéutica Arecor | n / a | n / a | n / a | n / a | n / a |
VPN (DI) de Argent Biopharma Limited | n / a | n / a | n / a | n / a | n / a |
AstraZeneca | £0 | £0 | £0 | £252,375 | - £ 900,725 |
Grupo Avacta | n / a | n / a | n / a | n / a | n / a |
Participaciones de referencia | £0 | £0 | £0 | £0 | £2,828,291 |
Beximco Pharmaceuticals Ltd. RDA (Reg S) | n / a | n / a | n / a | n / a | n / a |
Productos farmacéuticos Biodexa | n / a | n / a | n / a | n / a | n / a |
Biofrontera AG (DI) | n / a | n / a | n / a | n / a | n / a |
bioventix | £501 | £501 | £501 | - £ 2,602,823 | - £ 2,640,522 |
Terapéutica BiVictriX | n / a | n / a | n / a | n / a | n / a |
BTG | n / a | n / a | n / a | n / a | n / a |
Participaciones de descubrimiento C4X | £0 | £49,988 | £49,988 | £49,988 | £49,988 |
£0 | £0 | £0 | £43,148 | £43,148 | |
Grupo Chill Brands | n / a | n / a | n / a | n / a | n / a |
Participaciones de Cizzle Biotechnology | n / a | n / a | n / a | n / a | n / a |
ciprotex | n / a | n / a | n / a | n / a | n / a |
Dechra productos farmacéuticos | £0 | £0 | £0 | £48,244 | £48,244 |
Deepverge Plc | n / a | n / a | n / a | n / a | n / a |
Farmacia del destino | £0 | £0 | £0 | £0 | £63,462 |
Grupo diurno | n / a | n / a | n / a | n / a | n / a |
e-Terapéutica | £0 | £0 | £0 | £7,562 | £15,123 |
EastPharma Ltd RDA (Reg S) | n / a | n / a | n / a | n / a | n / a |
Grupo ECO de Sanidad Animal | £0 | £0 | £0 | £39,987 | £39,987 |
Investigación del Edén | n / a | n / a | n / a | n / a | n / a |
Ergonómico | n / a | n / a | n / a | n / a | n / a |
Faron Pharmaceuticals Oy (DI) | £0 | £59,951 | £59,951 | £59,951 | £40,936 |
Futura Médica | £0 | £0 | £0 | £0 | £0 |
Genflow Biociencias | n / a | n / a | n / a | n / a | n / a |
Género | £0 | £0 | £0 | £0 | - £ 119,184 |
GSK | £0 | £122,745,688 | £121,039,952 | £121,476,184 | £119,799,960 |
gunsynd | £0 | £2,392 | £6,832 | £6,832 | £6,832 |
GW Pharmaceuticals | n / a | n / a | n / a | n / a | n / a |
halcón | £0 | £0 | - £ 1,197,017 | - £ 680,858 | - £ 673,822 |
Productos farmacéuticos Hemogenyx | n / a | n / a | n / a | n / a | n / a |
Productos farmacéuticos de Hikma | £0 | £0 | £0 | £0 | £27,300 |
Grupo de descubrimiento de horizonte | n / a | n / a | n / a | n / a | n / a |
HUTCHMED (China) limitada | £0 | £0 | £0 | £0 | £5,874,709 |
hvivo | n / a | n / a | n / a | n / a | n / a |
immufarma | n / a | n / a | n / a | n / a | n / a |
individuo | £0 | £0 | - £ 1,825,388 | - £ 1,672,316 | - £ 1,672,316 |
Capital inspirado | n / a | n / a | n / a | n / a | n / a |
Ixico | n / a | n / a | n / a | n / a | n / a |
LungLife AI, Inc (DI) | £0 | £0 | £0 | £0 | £16,933 |
Maxcyte Inc (DI / REG S) | n / a | n / a | n / a | n / a | n / a |
Grupo Mereo Biopharma | n / a | n / a | n / a | n / a | n / a |
Motivo Bio | n / a | n / a | n / a | n / a | n / a |
Farmacia N4 | n / a | n / a | n / a | n / a | n / a |
Nuformix | n / a | n / a | n / a | n / a | n / a |
VAN de Okyo Pharma Limited | n / a | n / a | n / a | n / a | n / a |
VAN (CDI) de Ondine Biomedical Inc. | n / a | n / a | n / a | n / a | n / a |
Salud OptiBiotix | n / a | n / a | n / a | n / a | n / a |
Ovoca Bio (CDI) | n / a | n / a | n / a | n / a | n / a |
Oxford Biomédica | £0 | £0 | £0 | £19,281 | £370,517 |
Participaciones de Oxford Cannabinoid Technologies | £0 | £0 | £6,559 | £6,559 | - £ 269,323 |
Tecnologías Oxford Nanopore | £0 | £150 | £497,037 | £507,626 | £508,975 |
Pfizer Inc. | n / a | n / a | n / a | n / a | n / a |
OJSC Pharmstandard RDA (Reg S) | n / a | n / a | n / a | n / a | n / a |
Participaciones de Plethora Solutions | n / a | n / a | n / a | n / a | n / a |
Farmacia Poolbeg | £0 | £0 | £113,659 | £113,659 | £113,659 |
Ciencias del proteoma | n / a | n / a | n / a | n / a | n / a |
Salud PureTech | £0 | £0 | £0 | £0 | £0 |
Farmacéutica cuántica | n / a | n / a | n / a | n / a | n / a |
Farmacia redx | £0 | £48,901 | £48,901 | £48,901 | £48,901 |
Grupo ReNeuron | £0 | £0 | £0 | £0 | £29,433 |
Participaciones de Sareum | £0 | £0 | £19,500 | - £ 21,526 | - £ 7,696 |
Participaciones de Scancell | £0 | £0 | £0 | £80,000 | £80,000 |
Terapéutica de escudo | £0 | £0 | £0 | £122,000 | £122,000 |
Shire plc | n / a | n / a | n / a | n / a | n / a |
Terapéutica del silencio | n / a | n / a | n / a | n / a | n / a |
Farmacia Sinclair | n / a | n / a | n / a | n / a | n / a |
PielBioTerapéutica | n / a | n / a | n / a | n / a | n / a |
skyepharma | n / a | n / a | n / a | n / a | n / a |
Fuente BioScience | n / a | n / a | n / a | n / a | n / a |
Cumbre Terapéutica | n / a | n / a | n / a | n / a | n / a |
sinairgen | n / a | n / a | n / a | n / a | n / a |
Taiwán | n / a | n / a | n / a | n / a | n / a |
Theracryf | £0 | £47,761 | £47,761 | £47,761 | £47,761 |
Ciencias de la vida de Tiziana | n / a | n / a | n / a | n / a | n / a |
Valirx | n / a | n / a | n / a | n / a | n / a |
Grupo Vectura | n / a | n / a | n / a | n / a | n / a |
Verici DX | n / a | n / a | n / a | n / a | n / a |
Vernalis plc | n / a | n / a | n / a | n / a | n / a |
Farmacia Verona | n / a | n / a | n / a | n / a | n / a |
Verseon Corporation (DI / REG S) | n / a | n / a | n / a | n / a | n / a |
Corporación Verseon (Reg S Cat 3) | n / a | n / a | n / a | n / a | n / a |
Salud de Yourgene | n / a | n / a | n / a | n / a | n / a |